Bharat Chauhan, Diagnostic company, Metropolis Healthcare has been named Company of the Year in the Indian diagnostic services industry by Frost &.
Despite the Covid-19 outbreak, the company reported record revenue of INR 856 crores in
FY2020 against its earnings of INR 760 crores in FY2019, with growth of 12.6%. This revenue growth rate is higher than that of its competitors. The total number of patient visits to Metropolis Healthcare’s diagnostics centres in India has increased from 8.98 million in FY2019 to 10.00 million in FY2020, registering growth of 11.3% year-on-year (y-o-y).
Metropolis impressed Frost & Sullivan with its strong customer ownership experience,
particularly for offering customers easy accessibility, high-quality diagnostic tests, and report reliability. Moreover, the company educates its customers about their health status based on their personalized reports. Metropolis’ preventive care segment helps customers proactively take corrective measures, such as adopting a healthy lifestyle and predetermining, through testing, potential disorders for themselves and their families.
On being accorded the award, Ameera Shah, Promoter & Managing Director, Metropolis Healthcare said, “We are delighted to receive the prestigious ‘Company of the Year award’ by Frost & Sullivan. It is an absolute honour for the entire team at Metropolis to be recognised for our diligence and patient-centric approach. Even amidst the lockdown, our teams have relentlessly worked around the clock in tandem with our patient-first policy, delivering reliable pathology reports. Our in-depth understanding of patient needs, coupled with our unflinching commitment and the gravitas we bring to the table with our expertise, stands validated with an award of this stature. We are extremely inspired to take the next big leap and lead from the front in the Indian diagnostics space and unlock more potential in the near future.” The Frost & Sullivan award recognises Metropolis as unique in the diagnostics sector. Metropolis’ core brand values include integrity, empathy, and accuracy founded on a patient-first approach that creates value for all stakeholders. While congratulating Metropolis on the accomplishment, Pankaj Bedi, Consultant -Healthcare, Frost & Sullivan said, “In healthcare and the pathology industry, quality is the core driver of growth. Almost 70% of clinical decisions are based on diagnostic reports. Metropolis’ relentless focus on quality and reliability across its large range of diagnostic tests gives it unique brand positioning and increased revenue and growth margins. Metropolis’ way of doing business in the Indian diagnostic services industry stands out from that of its competitors. This is a well-deserved recognition for Metropolis supported by its robust financial